Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
The female pelvic implants market is projected to account for sales worth US$ 258.91 million by 2023. The market is projected to observe a CAGR of 2.8% in the forecast period, reaching US$ 341.26 million by 2033.
As per FMI, the top five players comprising Johnson & Johnson, Coloplast A/S, Becton, Dickinson and Company, Boston Scientific Corporation, and Cook Medical constitute around 75% of the overall market.
Market to Gain from Novel Tissue Engineering Launch for Female Pelvic Floor Reconstruction
Ongoing post-marketing surveillance of approved devices and the introduction of novel tissue engineering in female pelvic floor reconstruction creates huge opportunities in the female pelvic implants industry. The majority of manufacturers are selling their products in the global market despite strict regulations.
After the Food and Drug Administration’s (FDA) reclassification of vaginal mesh implants from Class II to Class III medical devices, the FDA has advised 33 manufacturers to conduct 3-year studies. It is to assess the impact of organ damage and other complications of mesh implants.
After assessing the risks, the manufacturers can reintroduce their devices and can get pre-market approval from the FDA. Further, this allows manufacturers to re-launch mesh implants, which are expected to enter the market. Similarly, the introduction of novel tissue engineering with growth factors, biomaterials, and drugs implanted into tissue damage or loss is set to boost repair time, stimulating the regeneration of damaged tissue.
Studies initiating tissue engineering for pelvic organ prolapse have reported the use of novel designed knit material fabricated from FDA-approved non-degradable polyamide dip-coated in gelatin for MSC seeding and delivery.
Polypropylene mesh commonly used in clinical practice has good mechanical properties, but there are long-term complications. This validates the need for tissue engineering technology in the treatment of pelvic organ prolapse and promotes an innovative approach to pelvic implantation.
What are the Factors Restraining Demand for Female Pelvic Implants?
As per the USFDA, the transvaginal placement of surgical mesh can be risky in women with POP mesh complications. Some of the common complications reported include mesh erosion, infections, vaginal scarring, discomfort and pain during sex, and even a resurgence of urinary incontinence.
Through January 31, 2019, over 139,000 adverse events have been reported for mesh products of which over 69,000 events were reported for POP mesh products, as per FDA, 2020. This restricts the patients from taking surgeries to implant vaginal mesh, thereby deterring market growth.
Growing awareness of surgical complications is curbing patients from opting for vaginal mesh implants in the high-growth markets of Europe and the United States.
Attributes | Details |
---|---|
Female Pelvic Implants Market Size (2023) | US$ 258.91 million |
Female Pelvic Implants Market Size (2033) | US$ 341.26 million |
Female Pelvic Implants Market CAGR (2023 to 2033) | 2.8% |
Female Pelvic Implants Market Size (2022) | US$ 251.86 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to Future Market Insights (FMI), the demand for female pelvic implants has grown at a 2.5% CAGR between 2018 and 2022.
According to the Division of Female Pelvic Medicine and Reconstructive Surgery at Northwestern University Chicago, women with normal life expectancy have an average 30-50% chance of developing pelvic organ prolapse. Around 19% of these women need to undergo at least one surgical intervention for POP or SUI and 30% of them undergo reoperation for recurrence. Despite such high prevalence, there is no definite cure or restoration of anatomical defects for pelvic organ prolapse or stress urinary incontinence.
In the last two decades, many efforts have been made to improve the outcomes of surgery. However, the majority of such efforts have resulted in the use of vaginal mesh and grafts. So far, surgical options with mesh implants and slings are proving to be the best option for such disorders which imply a heavy social and economic burden.
Other surgical options such as allografts and xenografts are costly and carry the potential of transmission of infectious disease and synthetic meshes. Thus, the market for female pelvic implants is expected to see continuous growth in the use of mesh and sling implants until definite alternatives are available for these products.
Future Market Insights expects the global female pelvic implants industry to rise at 2.8% CAGR between 2023 and 2033.
Female Pelvic Implants Market:
Attributes | Female Pelvic Implants Market |
---|---|
CAGR (2023 to 2033) | 2.8% |
Market Value (2033) | US$ 341.26 million |
Opportunity | Vigorous attempts by healthcare professionals to actively promote awareness about urinary continence in the majority of care settings. |
Key Trends | Increasing cases of stress urinary incontinence (SUI) to govern market growth in the following years. |
Female Stress Urinary Incontinence Treatment Devices Market:
Attributes | Female Stress Urinary Incontinence Treatment Devices Market |
---|---|
CAGR (2023 to 2033) | 6.2% |
Market Value (2033) | US$ 1.36 billion |
Opportunity | The rampant increase in gynecologic disorders and urinary incontinence is catalyzing the increase in demand. |
Key Trends | The debut of intravaginal devices and surge in the radiofrequency treatments to manage female SUI is expected to fuel market growth. |
Infectious Disease Diagnostics Market:
Attributes | Infectious Disease Diagnostics Market |
---|---|
CAGR (2023 to 2033) | 7% |
Market Value (2033) | US$ 3.72 billion |
Opportunity | Increasing proclivity for point-of-care testing is propelling big companies to focus on development projects to deliver point-of-care diagnostic solutions in developing countries. |
Key Trends | Numerous government-funded programs are providing free screening and tests worldwide, thus enlarging the market. |
The United States holds over 83% share of the female pelvic implants market in North America. As per the records of the Association for Pelvic Organ Prolapse Support, nearly 34 million women suffer from pelvic organ prolapse (POP) across the globe currently.
In the United States, the overall number of patients with POP is 3.3 million. According to the National Association for Incontinence, 25 million people in the United States suffer from some form of urinary incontinence, out of which 75% are women. Stress urinary incontinence (SUI) is the most prevalent form.
In the United States, about 15 million people are suffering from SUI. Thus, the rising prevalence of pelvic organ prolapse and stress urinary incontinence is driving the United States female pelvic implant market.
The United Kingdom market accounts for over 13% of Europe market through the assessment period ending in 2033. The governments of various countries in Europe like the United Kingdom are forming committees that can address the issues of women suffering from peri-operative complications of surgeries for pelvic implants. These programs are expected to raise awareness among patients, hospitals, and GPs and can increase the penetration of female pelvic implants over the forecast period. For instance,
India’s market accounts for more than 30% of the sales registered in South Asia in 2021. Most developing countries have patients that are not aware of conditions such as pelvic organ prolapse and stress urinary incontinence.
Perception of pain associated with surgery evokes considerable anxiety in patients resulting in a reluctance to consider surgical options to cure SUI or POP. Many women delay or do not seek treatment for these diseases in India due to a lack of awareness. It is forecasted to be the big challenge for the growth of female pelvic implants in India market.
Country | Australia |
---|---|
Forecast CAGR % (2023 to 2033) | 2.8% |
The market for female pelvic Implants in Australia is exhibiting a 2.8% CAGR and is projected to account for more than 86% of Oceania market throughout the projection period. Growing government initiatives to create awareness are anticipated to boost growth in the region. For instance,
Segment | Vaginal Sling/Tapes |
---|---|
Forecast CAGR (2023 to 2033) | 2.5% |
Vaginal sling/tapes have a high growth potential. The segment is likely to expand with a relatively high CAGR of 2.5% in the forthcoming years. Vaginal sling/tape implants are generally made from a narrow ‘tape’ of polypropylene mesh which is placed under the urethra like a sling or hammock to keep the urethra in the correct position.
Vaginal slings have been on the market for about 20 years and can be implanted in half-hour. The minimally invasive surgical procedure under local anesthesia is preferred for outpatient applications. Owing to these advantages, demand for vaginal sling/tapes is increasing during the forecast period.
Is the Stress Urinary Incontinence (SUI) Projected to Continue Fueling Female Pelvic Implants Demand?
The stress urinary incontinence (SUI) segment is expected to contribute maximum revenue share in the global female pelvic implants market. In terms of revenue, the stress urinary incontinence (SUI) segment accounted for over 58% share in 2022.
The demand for female pelvic implants is likely to witness solid growth on account of the prevalence of stress urinary incontinence and rising awareness among women regarding treatment options on a global scale.
Segment | Hospitals |
---|---|
Forecast CAGR (2023 to 2033) | 2.2% |
Hospitals are currently the leading end users of female pelvic implants with a 2.2% CAGR through the forecast period. Similarly, hospitals can impact high investment abilities and capital, with the surge in the number of emergency admissions, which is projected to enhance growth prospects for the long term.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Manufacturers are primarily focusing on developing new products to bolster the acceptance of female pelvic implants, thus anticipating the surge in sales figures. Further, the companies are focusing on outsourcing the production of female pelvic implants to reduce manufacturing costs, thereby challenging the market with reduced costs.
Key players are entering into collaborations, partnerships, acquisitions, and mergers to strengthen their product lines and global market.
Key Players Working in the Market:
Attribute | Details |
---|---|
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2018 to 2022 |
Market Analysis | US$ Million for Value in Million |
Key Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania Middle East & Africa |
Key Countries Covered | The United States, Canada, the United Kingdom, Germany, Italy, France, Spain, Benelux, Russia, India, Thailand, Malaysia, Indonesia, China, Japan, South Korea, Australia, New Zealand, GCC Countries, South Africa and North Africa |
Key Segments Covered | Product Type, Indication, End User, and Region |
Key Companies Profiled |
|
Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
Customization & Pricing | Available upon Request |
The CAGR for the market is 2.8% until 2033.
From 2018 to 2022, the market expanded at an 2.5% CAGR.
The market in 2023 totals US$ 258.91 million.
Promedon Group, Caldera Medical, Cook Medical are some key players.
The market will reach US$ 341.26 million by 2033.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033 5.3.1. Vaginal Mesh Implants 5.3.2. Vaginal Sling 5.3.3. Vaginal Graft Implants 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Indication, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Indication, 2023 to 2033 6.3.1. Pelvic Organ Prolapse 6.3.2. Stress Urinary Incontinence 6.4. Y-o-Y Growth Trend Analysis By Indication, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033 7.3.1. Hospitals 7.3.2. Ambulatory Surgical Centres 7.3.3. Speciality Clinics 7.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East & Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Product Type 9.2.3. By Indication 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By Indication 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Argentina 10.2.1.4. Rest of Latin America 10.2.2. By Product Type 10.2.3. By Indication 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Indication 10.3.4. By End User 10.4. Key Takeaways 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. UK 11.2.1.2. Germany 11.2.1.3. France 11.2.1.4. Italy 11.2.1.5. Spain 11.2.1.6. Rest of Western Europe 11.2.2. By Product Type 11.2.3. By Indication 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Indication 11.3.4. By End User 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Russia 12.2.1.2. Poland 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Product Type 12.2.3. By Indication 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Indication 12.3.4. By End User 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Product Type 13.2.3. By Indication 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Indication 13.3.4. By End User 13.4. Key Takeaways 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Product Type 14.2.3. By Indication 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Indication 14.3.4. By End User 14.4. Key Takeaways 15. Middle East & Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. Iran 15.2.1.2. Turkey 15.2.1.3. Rest of MEA 15.2.2. By Product Type 15.2.3. By Indication 15.2.4. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product Type 15.3.3. By Indication 15.3.4. By End User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Product Type 16.1.2.2. By Indication 16.1.2.3. By End User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Product Type 16.2.2.2. By Indication 16.2.2.3. By End User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Product Type 16.3.2.2. By Indication 16.3.2.3. By End User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Product Type 16.4.2.2. By Indication 16.4.2.3. By End User 16.5. Argentina 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Product Type 16.5.2.2. By Indication 16.5.2.3. By End User 16.6. UK 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Product Type 16.6.2.2. By Indication 16.6.2.3. By End User 16.7. Germany 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Product Type 16.7.2.2. By Indication 16.7.2.3. By End User 16.8. France 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Product Type 16.8.2.2. By Indication 16.8.2.3. By End User 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Product Type 16.9.2.2. By Indication 16.9.2.3. By End User 16.10. Spain 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Product Type 16.10.2.2. By Indication 16.10.2.3. By End User 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Product Type 16.11.2.2. By Indication 16.11.2.3. By End User 16.12. Poland 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Product Type 16.12.2.2. By Indication 16.12.2.3. By End User 16.13. Czech Republic 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Product Type 16.13.2.2. By Indication 16.13.2.3. By End User 16.14. Romania 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Product Type 16.14.2.2. By Indication 16.14.2.3. By End User 16.15. India 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Product Type 16.15.2.2. By Indication 16.15.2.3. By End User 16.16. Bangladesh 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Product Type 16.16.2.2. By Indication 16.16.2.3. By End User 16.17. Australia 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Product Type 16.17.2.2. By Indication 16.17.2.3. By End User 16.18. New Zealand 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Product Type 16.18.2.2. By Indication 16.18.2.3. By End User 16.19. China 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Product Type 16.19.2.2. By Indication 16.19.2.3. By End User 16.20. Japan 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Product Type 16.20.2.2. By Indication 16.20.2.3. By End User 16.21. South Korea 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Product Type 16.21.2.2. By Indication 16.21.2.3. By End User 16.22. Iran 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2022 16.22.2.1. By Product Type 16.22.2.2. By Indication 16.22.2.3. By End User 16.23. Turkey 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2022 16.23.2.1. By Product Type 16.23.2.2. By Indication 16.23.2.3. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product Type 17.3.3. By Indication 17.3.4. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Johnson & Johnson Services, Inc. 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Coloplast A/S 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Dipromed Srl 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Boston Scientific Corporation 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. pfm medical ag 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Betatech Medical 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Promedon Group 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Caldera Medical 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. Cook Medical 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033 Table 2: Global Market Value (US$ Million) Forecast by Product Type, 2018 to 2033 Table 3: Global Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 4: Global Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 6: North America Market Value (US$ Million) Forecast by Product Type, 2018 to 2033 Table 7: North America Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 8: North America Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 10: Latin America Market Value (US$ Million) Forecast by Product Type, 2018 to 2033 Table 11: Latin America Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 12: Latin America Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 13: Western Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 14: Western Europe Market Value (US$ Million) Forecast by Product Type, 2018 to 2033 Table 15: Western Europe Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 16: Western Europe Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 17: Eastern Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 18: Eastern Europe Market Value (US$ Million) Forecast by Product Type, 2018 to 2033 Table 19: Eastern Europe Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 20: Eastern Europe Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 21: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 22: South Asia and Pacific Market Value (US$ Million) Forecast by Product Type, 2018 to 2033 Table 23: South Asia and Pacific Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 24: South Asia and Pacific Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 25: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 26: East Asia Market Value (US$ Million) Forecast by Product Type, 2018 to 2033 Table 27: East Asia Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 28: East Asia Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 29: Middle East & Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 30: Middle East & Africa Market Value (US$ Million) Forecast by Product Type, 2018 to 2033 Table 31: Middle East & Africa Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 32: Middle East & Africa Market Value (US$ Million) Forecast by End User, 2018 to 2033
Figure 1: Global Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 2: Global Market Value (US$ Million) by Indication, 2023 to 2033 Figure 3: Global Market Value (US$ Million) by End User, 2023 to 2033 Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033 Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033 Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 8: Global Market Value (US$ Million) Analysis by Product Type, 2018 to 2033 Figure 9: Global Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 10: Global Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 11: Global Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 12: Global Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 13: Global Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 14: Global Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 15: Global Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 16: Global Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 17: Global Market Attractiveness by Product Type, 2023 to 2033 Figure 18: Global Market Attractiveness by Indication, 2023 to 2033 Figure 19: Global Market Attractiveness by End User, 2023 to 2033 Figure 20: Global Market Attractiveness by Region, 2023 to 2033 Figure 21: North America Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 22: North America Market Value (US$ Million) by Indication, 2023 to 2033 Figure 23: North America Market Value (US$ Million) by End User, 2023 to 2033 Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033 Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 28: North America Market Value (US$ Million) Analysis by Product Type, 2018 to 2033 Figure 29: North America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 30: North America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 31: North America Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 32: North America Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 33: North America Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 34: North America Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 35: North America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 36: North America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 37: North America Market Attractiveness by Product Type, 2023 to 2033 Figure 38: North America Market Attractiveness by Indication, 2023 to 2033 Figure 39: North America Market Attractiveness by End User, 2023 to 2033 Figure 40: North America Market Attractiveness by Country, 2023 to 2033 Figure 41: Latin America Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 42: Latin America Market Value (US$ Million) by Indication, 2023 to 2033 Figure 43: Latin America Market Value (US$ Million) by End User, 2023 to 2033 Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033 Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 48: Latin America Market Value (US$ Million) Analysis by Product Type, 2018 to 2033 Figure 49: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 51: Latin America Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 52: Latin America Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 54: Latin America Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 55: Latin America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 57: Latin America Market Attractiveness by Product Type, 2023 to 2033 Figure 58: Latin America Market Attractiveness by Indication, 2023 to 2033 Figure 59: Latin America Market Attractiveness by End User, 2023 to 2033 Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033 Figure 61: Western Europe Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 62: Western Europe Market Value (US$ Million) by Indication, 2023 to 2033 Figure 63: Western Europe Market Value (US$ Million) by End User, 2023 to 2033 Figure 64: Western Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 65: Western Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 66: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 67: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 68: Western Europe Market Value (US$ Million) Analysis by Product Type, 2018 to 2033 Figure 69: Western Europe Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 70: Western Europe Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 71: Western Europe Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 72: Western Europe Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 73: Western Europe Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 74: Western Europe Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 75: Western Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 76: Western Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 77: Western Europe Market Attractiveness by Product Type, 2023 to 2033 Figure 78: Western Europe Market Attractiveness by Indication, 2023 to 2033 Figure 79: Western Europe Market Attractiveness by End User, 2023 to 2033 Figure 80: Western Europe Market Attractiveness by Country, 2023 to 2033 Figure 81: Eastern Europe Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 82: Eastern Europe Market Value (US$ Million) by Indication, 2023 to 2033 Figure 83: Eastern Europe Market Value (US$ Million) by End User, 2023 to 2033 Figure 84: Eastern Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 85: Eastern Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 88: Eastern Europe Market Value (US$ Million) Analysis by Product Type, 2018 to 2033 Figure 89: Eastern Europe Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 90: Eastern Europe Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 91: Eastern Europe Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 92: Eastern Europe Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 93: Eastern Europe Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 94: Eastern Europe Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 95: Eastern Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 96: Eastern Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 97: Eastern Europe Market Attractiveness by Product Type, 2023 to 2033 Figure 98: Eastern Europe Market Attractiveness by Indication, 2023 to 2033 Figure 99: Eastern Europe Market Attractiveness by End User, 2023 to 2033 Figure 100: Eastern Europe Market Attractiveness by Country, 2023 to 2033 Figure 101: South Asia and Pacific Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 102: South Asia and Pacific Market Value (US$ Million) by Indication, 2023 to 2033 Figure 103: South Asia and Pacific Market Value (US$ Million) by End User, 2023 to 2033 Figure 104: South Asia and Pacific Market Value (US$ Million) by Country, 2023 to 2033 Figure 105: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 106: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 107: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 108: South Asia and Pacific Market Value (US$ Million) Analysis by Product Type, 2018 to 2033 Figure 109: South Asia and Pacific Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 110: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 111: South Asia and Pacific Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 112: South Asia and Pacific Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 113: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 114: South Asia and Pacific Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 115: South Asia and Pacific Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 116: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 117: South Asia and Pacific Market Attractiveness by Product Type, 2023 to 2033 Figure 118: South Asia and Pacific Market Attractiveness by Indication, 2023 to 2033 Figure 119: South Asia and Pacific Market Attractiveness by End User, 2023 to 2033 Figure 120: South Asia and Pacific Market Attractiveness by Country, 2023 to 2033 Figure 121: East Asia Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 122: East Asia Market Value (US$ Million) by Indication, 2023 to 2033 Figure 123: East Asia Market Value (US$ Million) by End User, 2023 to 2033 Figure 124: East Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 125: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 126: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 127: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 128: East Asia Market Value (US$ Million) Analysis by Product Type, 2018 to 2033 Figure 129: East Asia Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 130: East Asia Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 131: East Asia Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 132: East Asia Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 133: East Asia Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 134: East Asia Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 135: East Asia Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 136: East Asia Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 137: East Asia Market Attractiveness by Product Type, 2023 to 2033 Figure 138: East Asia Market Attractiveness by Indication, 2023 to 2033 Figure 139: East Asia Market Attractiveness by End User, 2023 to 2033 Figure 140: East Asia Market Attractiveness by Country, 2023 to 2033 Figure 141: Middle East & Africa Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 142: Middle East & Africa Market Value (US$ Million) by Indication, 2023 to 2033 Figure 143: Middle East & Africa Market Value (US$ Million) by End User, 2023 to 2033 Figure 144: Middle East & Africa Market Value (US$ Million) by Country, 2023 to 2033 Figure 145: Middle East & Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 146: Middle East & Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 147: Middle East & Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 148: Middle East & Africa Market Value (US$ Million) Analysis by Product Type, 2018 to 2033 Figure 149: Middle East & Africa Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 150: Middle East & Africa Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 151: Middle East & Africa Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 152: Middle East & Africa Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 153: Middle East & Africa Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 154: Middle East & Africa Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 155: Middle East & Africa Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 156: Middle East & Africa Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 157: Middle East & Africa Market Attractiveness by Product Type, 2023 to 2033 Figure 158: Middle East & Africa Market Attractiveness by Indication, 2023 to 2033 Figure 159: Middle East & Africa Market Attractiveness by End User, 2023 to 2033 Figure 160: Middle East & Africa Market Attractiveness by Country, 2023 to 2033
Recommendations
Explore Healthcare Insights
View Reports